Repros Therapeutics Inc (RPRX)

[corpstrat]

<<most of what Thomas states appears to be true.>>

Thomas said two things in that post, neither of which was true.

1. He said nobody implied the FDA might reject the IND. I corrected that a few minutes ago.

2. He said the anemia program is now badly delayed and the IND is months away. But Repros says the anemia trial is on track to begin Q1 2008. So the Nov 30 meeting did not represent months of delay and the IND is not months away.

What is left in what Thomas stated that appears to you to be true?